Template Description
2yub: SOLUTION STRUCTURE OF THE PDZ DOMAIN FROM MOUSE LIM DOMAINKINASE Solved by: NMR, Identified by BLAST
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1x6a: SOLUTION STRUCTURES OF THE SECOND LIM DOMAIN OF HUMAN LIM-KINASE 2 (LIMK2) Solved by: NMR, Identified by BLAST
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
62-132
1x6aA
94%
>target
-------KDYWAKFGEFCHGCSLLMTGPAMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVLAP---
>1x6aA
GSSGSSGKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVSGPSSG
[Model]
3s95: CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPSTAUROSPORINE Solved by: X-RAY, Resolution: 1.65A, Identified by BLAST
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
320-623
3s95A
65%
>target
SYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDP-FPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFLGELAIPLPAELEDLD------------
>3s95A
SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV--------------------------YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG-HLPLGPQLEQLDRGFWETYRRGES
[Model]
320-623
3s95B
65%
>target
SYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDP-FPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFLGELAIPLPAELEDLD------------
>3s95B
SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV--------------------------YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG-HLPLGPQLEQLDRGFWETYRRGES
[Model]
3ppz: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH ST Solved by: X-RAY, Resolution: 2.99A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-604
3ppzA
29%
>target
------FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV---DPFPWQQKVRFAKGISSGMAYLHSMC--IIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEAL--
>3ppzA
DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILME--AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTF--------------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
326-605
3ppzB
27%
>target
------FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV---DPFPWQQKVRFAKGISSGMAYLHSMC--IIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS-
>3ppzB
DGDDMDIPWCDLNIKEKIG----ATVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTF--------------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
3p86: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN MUTANT D676N IN COSTAUROSPORINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-605
3p86A
26%
>target
--FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV---DPFPWQQKVRFAKGISSGMAYLHSMC--IIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS-
>3p86A
MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGTPE-------------------------------------WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
326-604
3p86B
26%
>target
---FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV---DPFPWQQKVRFAKGISSGMAYLHSMC--IIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEAL--
>3p86B
DMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKIL----------FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGTPE-------------------------------------WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
3nyx: NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZTHIOPHENE INHIBITOR Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
325-607
3nyxA
25%
>target
--IFRPCDLIHGEVLGKGFFGQAIKVTHKA--TGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYK-DKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDF-------------GLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF---
>3nyxA
PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQEKSLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-----------------VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRH
[Model]
4e1z: STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE IN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
325-607
4e1zA
25%
>target
----IFRPCDLIHGEVLGKGFFGQAIKVTHKA----TGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYA-DPDCLPRT------------LDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF--
>4e1zA
SDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCE-DKSVQLVMEYVPLGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-----------------RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ
[Model]
3nz0: NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
325-607
3nz0A
25%
>target
---IFRPCDLIHGEVLGKGFFGQAIKVTHKA----TGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKD--KKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADP--DCLPRT--LD-FGLN--VKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF---
>3nz0A
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-----------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRH
[Model]
3lxn: STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
325-608
3lxnA
24%
>target
---IFRPCDLIHGEVLGKGFFGQAIKVTHKA----TGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKD--KKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLD-------------FGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFL--
>3lxnA
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--------------------YYRVGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG
[Model]
3lxp: STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
325-608
3lxpA
24%
>target
---IFRPCDLIHGEVLGKGFFGQAIKVTHKA--TGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKD--KKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTL-------------DFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFL--
>3lxpA
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--------------------YYRVGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG
[Model]
4e20: STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE IN Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
324-607
4e20A
24%
>target
--QIFRPCDLIHGEVLGKGFFGQAIKVTHKA----TGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYA-DPDCLPRTLDF------GL--NVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF--
>4e20A
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED--SVQLVMEYVPLGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-----------------RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ
[Model]
3t9t: CRYSTAL STRUCTURE OF BTK MUTANT (F435T,K596R) COMPLEXED WIIMIDAZO[1,5-A]QUINOXALINE Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
3t9tA
23%
>target
--FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRS-VDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-
>3t9tA
WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
3qgy: CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
325-606
3qgyA
23%
>target
--IFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-
>3qgyA
HMVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES
[Model]
326-605
3qgyB
23%
>target
--FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRS-VDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS
>3qgyB
MVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTP-----------------------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA
[Model]
3mj2: X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BM Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-604
3mj2A
23%
>target
-FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEAL
>3mj2A
VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI
[Model]
4hct: CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
4hctA
23%
>target
----FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-
>4hctA
GKWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
4hcu: CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
4hcuA
23%
>target
--FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-
>4hcuA
WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
1ogu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6- AMINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-605
1oguA
21%
>target
---PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNV----------------KLFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>1oguA
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
328-606
1oguC
23%
>target
---PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-----
>1oguC
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qgw: CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-606
3qgwA
23%
>target
-RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-
>3qgwA
IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIKEG-SMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGFPV------------------------------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES
[Model]
1oiu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-605
1oiuA
21%
>target
---PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNV----------------KLFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>1oiuA
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
329-604
1oiuC
23%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>1oiuC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQ--LFRIFRTLG-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3emg: DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2- PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-604
3emgA
23%
>target
--PCDLIHGE-VLGKGFFGQAIKVTHK-ATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEAL--
>3emgA
LDRKLLTLEDKELGSGNFGTVKKGYYQMKVVKTVAVKILKL-----KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE---------------------NYYKAKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY
[Model]
4hcv: CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
4hcvA
23%
>target
--FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-
>4hcvA
WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
1snx: CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 3.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
1snxA
23%
>target
-FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>1snxA
VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
326-606
1snxB
23%
>target
-FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>1snxB
VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3tub: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-(5-(6,7- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-3-((1R,2S)-2- PHENYLCYCLOPROPYL)UREA Solved by: X-RAY, Resolution: 2.23A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-605
3tubA
22%
>target
----RPCDLIHG-EVLGKGFFGQAIKVTHKA--TGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS---
>3tubA
EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLPV------------------------------------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
3v8w: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469 Solved by: X-RAY, Resolution: 2.27A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
3v8wA
22%
>target
---FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>3v8wA
GSVIDPSELTFVQEIGSG--GLVHLGYWLN-KDKVAIKTIRGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI--PYERSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
325-606
3v8wB
22%
>target
--IFRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVY-ADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>3v8wB
GSVIDPSELTFVQEIGSG--GLVHLGYWLN-KDKVAIKTIRMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-S-NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
4gcj: CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 Solved by: X-RAY, Resolution: 1.42A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
4gcjA
22%
>target
-------CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF------W-------------EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>4gcjA
LGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3vf9: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC THIENOPYRAZOLYLINDOLE INHIBITOR 027 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-607
3vf9A
22%
>target
---PCDLIHGE-VLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIG-QVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF---
>3vf9A
YLDRKLLTLEDKELGSGNFGTVKKGYQMKVVKTVAVKILP----ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-----------------QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
4f4p: SYK IN COMPLEX WITH LIGAND LASW836 Solved by: X-RAY, Resolution: 2.37A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-606
4f4pA
22%
>target
--PCDLIHGE-VLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL------
>4f4pA
LDRKLLTLEDKELGSGNFGTVKKGYVK----TVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-----------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG
[Model]
1h25: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1h25A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF------------------W----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL----
>1h25A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
329-604
1h25C
22%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------L-----FWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL----
>1h25C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
3fqe: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHYM193306 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-607
3fqeA
22%
>target
----PCDLIHGE-VLGKGFFGQAIKVTHKAT--GKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF-------
>3fqeA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--------------------YYKAQKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
3tuc: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-BENZYL-N-(5-DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-2-OXO-1,2-DIHYDROCARBOXAMIDE Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-604
3tucA
22%
>target
-------FRPCDLIHG-EVLGKGFFGQAIKVTHK--ATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEAL----
>3tucA
IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLPV------------------------------------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
1xba: CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-606
1xbaA
22%
>target
----PCDLIHGE-VLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-----
>1xbaA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMVVKTVAVKILPA----LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
1snu: CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
1snuA
23%
>target
-FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>1snuA
VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
327-605
1snuB
22%
>target
-RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS-
>1snuB
IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFPVK--------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE
[Model]
4fl3: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
4fl3A
22%
>target
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------CDLIHG-EVLGKGFFGQAIKVTHKATG--KVMVMKELIRC--DEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF---
>4fl3A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL------------------------------RAPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3vf8: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC PYRAZOLYLBENZIMIDAZOLE INHIBITOR 416 Solved by: X-RAY, Resolution: 2.08A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-606
3vf8A
22%
>target
----PCDLIHG-EVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL----
>3vf8A
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMVVKTVAVKILPA----LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3v5l: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542 Solved by: X-RAY, Resolution: 1.86A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-605
3v5lC
22%
>target
---FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS
>3v5lC
GSVIDPSEL---TFVQEIGSGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTF----------------------------------PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA
[Model]
326-606
3v5lD
22%
>target
---FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>3v5lD
GSVIDPSELTFVQEIGSG-QGLVHLGYWL-NKDKVAIKTIRAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMFP-----------------------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3srv: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLDIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 1.95A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-606
3srvA
22%
>target
----DLIHGEVLGKGFFGQAIKVTHKATG--KVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL---
>3srvA
YLDRKLLTLEDKELGNFGTVKKGYYQMKKVVKTVAVKILK----ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-----------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV
[Model]
328-604
3srvB
22%
>target
---PCDLIHGE-VLGKGFFGQAIKVTHKATG--KVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIG-QVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEAL---
>3srvB
YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL----PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD
[Model]
1xbc: CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-607
1xbcA
22%
>target
----PCDLIHGE-VLGKGFFGQAIKVTHKATG--KVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF----
>1xbcA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILP----ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-----------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
4fl2: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 2.19A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-608
4fl2A
22%
>target
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FRPCDLIHGE-VLGKGFFGQAIKVTHKATG--KVMVMKELIRC--DEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLFL--
>4fl2A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ-----------------THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
1sm2: CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
1sm2A
23%
>target
-FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>1sm2A
VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK-------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
327-605
1sm2B
22%
>target
-RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS-
>1sm2B
IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFPVK--------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE
[Model]
3fqs: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHR406 Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-607
3fqsA
22%
>target
---RPCDLIHGE-VLGKGFFGQAIKVTHKAT--GKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIG-QVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF-------
>3fqsA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---------------------YYKAKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
4fl1: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 1.79A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-606
4fl1A
22%
>target
---RPCDLIHG-EVLGKGFFGQAIKVTHKATG--KVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL----
>4fl1A
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---KPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-----------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
1xbb: CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-607
1xbbA
22%
>target
---RPCDLIHGE-VLGKGFFGQAIKVTHKAT--GKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIG-QVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF-------
>1xbbA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---------------------YYKAKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
3v8t: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
3v8tB
22%
>target
---FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQV-YADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL--
>3v8tB
GSVIDPSELTFVQEIGSG--GLVHLGYWLN-KDKVAIKTIAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTP-----------------------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3v5j: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090 Solved by: X-RAY, Resolution: 2.59A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
326-606
3v5jB
22%
>target
---FRPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV-DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL---
>3v5jB
GSVIDPSELTFVQEIGSG--GLVHLGYWL-NKDKVAIKTIMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFPVK--------------------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL
[Model]
4dfn: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHADAMANTYLPYRAZINE INHIBITOR Solved by: X-RAY, Resolution: 2.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-607
4dfnA
22%
>target
----PCDLIHG-EVLGKGFFGQAIKVTHKAT--GKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSLF----
>4dfnA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-----------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
2g9x: STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2g9xA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2g9xA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-606
2g9xC
23%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF--WEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>2g9xC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h26: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1h26A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h26A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-604
1h26C
22%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>1h26C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFR-TLGTVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2iw6: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2iw6A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL------
>2iw6A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
329-604
2iw6C
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL------
>2iw6C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
3qql: CDK2 IN COMPLEX WITH INHIBITOR L3 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qqlA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qqlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxj: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMI Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1pxjA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1pxjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3roy: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3royA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3royA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ej1: CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3ej1A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3ej1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
3ej1C
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>3ej1C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3qqg: CDK2 IN COMPLEX WITH INHIBITOR L2-5 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qqgA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qqgA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c4g: STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-604
2c4gA
21%
>target
---RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL--------
>2c4gA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
328-605
2c4gC
21%
>target
--PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2c4gC
VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2w1h: FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA (AT9283)A MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2w1hA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------L--------------F------WEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2w1hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-------------------------------AFVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rjc: CDK2 IN COMPLEX WITH INHIBITOR L4-12 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rjcA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rjcA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2a0c: HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9- TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR Solved by: X-RAY, Resolution: 1.95A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2a0cX
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>2a0cX
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3r1s: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r1sA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r1sA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1w8c: CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9HPURIN-2-YLAMINE AND MONOMERIC CDK2 Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1w8cA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1w8cA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2a4l: HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITIN Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2a4lA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL------FW-------------E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2a4lA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIA----------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3g: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.96A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3gA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNV------KLFW-------------EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3gA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA---------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9d: CDK2 IN COMPLEX WITH INHIBITOR RC-2-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r9dA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r9dA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8p: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r8pA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r8pA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8l: CDK2 IN COMPLEX WITH INHIBITOR L3-4 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r8lA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r8lA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3tiy: CDK2 IN COMPLEX WITH NSC 35676 Solved by: X-RAY, Resolution: 2.02A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-606
3tiyA
21%
>target
-DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-----------------------WE---KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3tiyA
ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtr: CDK2 IN COMPLEX WITH INHIBITOR RC-1-148 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3qtrA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3qtrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9n: CDK2 IN COMPLEX WITH INHIBITOR RC-2-21 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3r9nA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3r9nA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3k: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3kA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW-------EK---FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3kA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------------------------------VVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5x: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2c5xA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2c5xC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5xC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2b54: HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN- 232305 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2b54A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2b54A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtq: CDK2 IN COMPLEX WITH INHIBITOR RC-1-137 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qtqA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qtqA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ke9: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4- ({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1ke9A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL---------
>1ke9A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA------------------------------FVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3bhv: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR VARIOLIN B Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-605
3bhvA
21%
>target
--PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3bhvA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
328-605
3bhvC
23%
>target
--PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>3bhvC
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3lfs: CRYSTAL STRUCTURE OF CDK2 WITH SAR37, AN AMINOINDAZOLE TYPINHIBITOR Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3lfsA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3lfsA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rm7: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rm7A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rm7A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c68: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2c68A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LF----------WE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2c68A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1fq1: CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) ICOMPLEX WITH PHOSPHO-CDK2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1fq1B
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1fq1B
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3rk7: CDK2 IN COMPLEX WITH INHIBITOR RC-2-71 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rk7A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rk7A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzg: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qzgA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qzgA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qhw: STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC Solved by: X-RAY, Resolution: 2.17A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
3qhwA
21%
>target
---CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WEK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>3qhwA
GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-604
3qhwC
21%
>target
---CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WEK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>3qhwC
GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3pj8: STRUCTURE OF CDK2 IN COMPLEX WITH A PYRAZOLO[4,3-D]PYRIMIDBIOISOSTERE OF ROSCOVITINE. Solved by: X-RAY, Resolution: 1.96A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3pj8A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3pj8A
GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3eid: CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR Solved by: X-RAY, Resolution: 3.15A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3eidA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>3eidA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----------------------RTYTVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
329-605
3eidC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF------------------------W--EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>3eidC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR----------------------TYTHVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
4ez3: CDK2 IN COMPLEX WITH NSC 134199 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
4ez3A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>4ez3A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ol2: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F- PHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1ol2A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1ol2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1ol2C
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1ol2C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r9h: CDK2 IN COMPLEX WITH INHIBITOR RC-2-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r9hA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r9hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ke5: CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H- INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1ke5A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL---------
>1ke5A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA------------------------------FVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wxv: STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2wxvC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2wxvC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
327-605
2wxvA
21%
>target
---RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL--------------------------FWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2wxvA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pkd: THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1pkdA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1pkdA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1pkdC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1pkdC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r8z: CDK2 IN COMPLEX WITH INHIBITOR RC-1-136 Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r8zA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r8zA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rpoA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rpoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qx2: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qx2A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qx2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qwk: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qwkA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qwkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxr: APO CDK2 CRYSTALLIZED FROM JEFFAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3pxrA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3pxrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3o: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3oA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uue: REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDINGGROOVE INHIBITORS Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2uueA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2uueA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2uueC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2uueC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3fz1: CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2) Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3fz1A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW----------------E----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3fz1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGH---------------------------EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxi: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2- YLAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1pxiA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1pxiA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1vyw: STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-605
1vywA
21%
>target
---RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL--------------------------FWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1vywA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
1vywC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1vywC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4erw: CDK2 IN COMPLEX WITH STAUROSPORINE Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-608
4erwA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF----------------W-------E---KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLFL-----
>4erwA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLG---VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2cci: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITHA PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2cciA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2cciA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2cciC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2cciC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qxo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qxoA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qxoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ddp: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR CR8 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3ddpC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3ddpC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
3ddpA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>3ddpA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3pxy: CDK2 IN COMPLEX WITH INHIBITOR JWS648 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3pxyA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3pxyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpv: CDK2 IN COMPLEX WITH INHIBITOR RC-2-88 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rpvA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rpvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxn: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)- PYRIMIDIN-2-YLAMINO]-PHENOL Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1pxnA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1pxnA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2v0d: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-605
2v0dA
21%
>target
--DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LFWE--------------------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2v0dA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ns9: CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH INHIBITOR BS-194 Solved by: X-RAY, Resolution: 1.78A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-605
3ns9A
21%
>target
DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------L----------F---WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3ns9A
NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIGV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6m: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2c6mA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LF----------WE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2c6mA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3f5x: CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITACTIVE SITE Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
3f5xA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL-----------------------FW---EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL---------
>3f5xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP-KRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
3f5xC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3f5xC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9o: CDK2 IN COMPLEX WITH INHIBITOR RC-2-143 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3r9oA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3r9oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7e: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r7eA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r7eA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wma: STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OLIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2wmaA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2wmaA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-604
2wmaC
23%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2wmaC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQ--LFRIFRTLG-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1buh: CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1buhA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNV----------------KLFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-----
>1buhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-----DTTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
1jsv: THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE Solved by: X-RAY, Resolution: 1.96A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1jsvA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNV------KLFW-------------EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1jsvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA---------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzo: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2uzoA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LF----------WE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2uzoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r8v: CDK2 IN COMPLEX WITH INHIBITOR RC-1-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r8vA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r8vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtw: CDK2 IN COMPLEX WITH INHIBITOR RC-2-13 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qtwA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qtwA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4dfl: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHSULFONAMIDOPYRAZINE PIPERIDINE INHIBITOR Solved by: X-RAY, Resolution: 1.98A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
4dflA
21%
>target
-----CDLIH-GEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALSL-----
>4dflA
VYLDRKLLTLEDKELGSGTVKKGYY---QMVVKTVAVKILP----ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-----------------QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
3rpr: CDK2 IN COMPLEX WITH INHIBITOR RC-2-49 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3rprA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3rprA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r73: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r73A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r73A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7u: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-75 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3r7uA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3r7uA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wev: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 2.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2wevA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-----
>2wevA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
329-605
2wevC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2wevC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r1y: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r1yA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r1yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h1r: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1h1rA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h1rA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1h1rC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h1rC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qqk: CDK2 IN COMPLEX WITH INHIBITOR L4 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qqkA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qqkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rzb: CDK2 IN COMPLEX WITH INHIBITOR RC-2-23 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3rzbA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3rzbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1oiy: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1oiyA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1oiyA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1oiyC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1oiyC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r83: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r83A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r83A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7y: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r7yA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r7yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rm6: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80 Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rm6A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW-------------------EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rm6A
MENFQKVEKIGEGT-GVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3eoc: CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3eocA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3eocA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
3eocC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>3eocC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qts: CDK2 IN COMPLEX WITH INHIBITOR RC-2-12 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3qtsA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3qtsA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7i: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-74 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3r7iA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3r7iA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rni: CDK2 IN COMPLEX WITH INHIBITOR RC-3-86 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rniA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rniA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h0v: HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THINHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1h0vA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1h0vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-----------------------RTEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rk9: CDK2 IN COMPLEX WITH INHIBITOR RC-2-74 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rk9A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rk9A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7v: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r7vA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r7vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4ez7: CDK2 IN COMPLEX WITH STAUROSPORINE AND 2 MOLECULES OF 8-ANNAPHTHALENE SULFONIC ACID Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
4ez7A
21%
>target
-----CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL------------------------FWE--KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>4ez7A
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ke7: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2- DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1ke7A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL---------
>1ke7A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA------------------------------FVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1okv: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1okvA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-----
>1okvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
329-605
1okvC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR-CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1okvC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qwj: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qwjA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qwjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3py1: CDK2 TERNARY COMPLEX WITH SU9516 AND ANS Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3py1A
21%
>target
-----CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL------------------------FWE--KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3py1A
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1urc: CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1urcA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1urcA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1urcC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1urcC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2uzb: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2uzbA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2uzbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2uzbC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2uzbC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2r3j: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3jA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3jA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-------------------------------EVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8u: CDK2 IN COMPLEX WITH INHIBITOR RC-1-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r8uA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r8uA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wfy: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 2.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2wfyA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-----
>2wfyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
329-605
2wfyC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2wfyC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2cch: THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2cchA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2cchA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2cchC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2cchC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1fvv: THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1fvvA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1fvvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
1fvvC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1fvvC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h24: CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1h24A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF------------------W----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL----
>1h24A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
329-604
1h24C
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF------------------W----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL----
>1h24C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
3qzh: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qzhA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qzhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5n: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2c5nA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5nA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2c5nC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5nC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2whb: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2whbA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2whbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2whbC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2whbC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3sw4: CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRINHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3sw4A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE---K-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3sw4A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR------------------------------AFGVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h28: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1h28A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h28A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1h28C
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h28C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1p5e: THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS) Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1p5eA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1p5eA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1p5eC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1p5eC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2x1n: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2x1nC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2x1nC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2x1nA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2x1nA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3rkb: CDK2 IN COMPLEX WITH INHIBITOR RC-2-73 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rkbA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rkbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r6x: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3r6xA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3r6xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxo: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1pxoA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1pxoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3tud: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH N-(4-METHYL-3-OXO-2-(PHENYLAMINO)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-6-Y(TRIFLUOROMETHYL)BENZAMIDE Solved by: X-RAY, Resolution: 2.33A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-605
3tudA
21%
>target
---RPCDLIHGE-VLGKGFFGQAIKVTHKA--TGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS------
>3tudA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGKW-----------------------------------PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNH
[Model]
1h1s: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1h1sA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h1sA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1h1sC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h1sC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qrt: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qrtA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qrtA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2v22: REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDINGGROOVE INHIBITORS Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2v22C
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2v22C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2v22A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2v22A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2wmb: STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OLIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2wmbA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2wmbA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-604
2wmbC
23%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2wmbC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--D--QLFRIFRTLKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1fin: CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1finA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1finA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
1finC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1finC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2iw8: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2iw8A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL--------
>2iw8A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
329-604
2iw8C
22%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2iw8C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--ID--QLFRIFRTLG-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2r3m: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3mA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3mA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-------------------------------EVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxp: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLN',N'-DIMETHYL-BENZENE-1,4-DIAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1pxpA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1pxpA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3fqh: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHA 2-SUBSTITUTED 7-AZAINDOLE Solved by: X-RAY, Resolution: 2.26A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
336-605
3fqhA
21%
>target
--------VLGKGFFGQAIKVTHKAT--GKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS----
>3fqhA
VYLDRKLLTLEDKELGTVKKGYYQMKKVVKTVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-----------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV
[Model]
336-605
3fqhB
21%
>target
-------------VLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVDPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQ-VYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKLEDSFEALS---
>3fqhB
VYLDRKLLTLEDKELGSTVKKGYYQMKK--VVKTVAVKILK---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---------------------YYKAKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
3qxp: CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qxpA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qxpA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2xnb: DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YPYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2xnbA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------------L----FW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2xnbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2clx: 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDCRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
2clxA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------L----------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>2clxA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLG---VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--------------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3s00: CDK2 IN COMPLEX WITH INHIBITOR L4-14 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3s00A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3s00A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1jvp: CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365 Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
1jvpP
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL---------
>1jvpP
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA------------------------------FVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtx: CDK2 IN COMPLEX WITH INHIBITOR RC-2-35 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qtxA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qtxA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c69: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-605
2c69A
21%
>target
--DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LFWE--------------------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2c69A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1y91: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[5-A]PYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.15A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-605
1y91A
21%
>target
--DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWEK----------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1y91A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGYT-------------------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3i: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3iA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3iA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5v: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2c5vA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
2c5vC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5vC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2c6k: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-605
2c6kA
21%
>target
--DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LFWE--------------------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2c6kA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3unk: CDK2 IN COMPLEX WITH INHIBITOR YL5-083 Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3unkA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3unkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1jsu: P27(KIP1)/CYCLIN A/CDK2 COMPLEX Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
340-605
1jsuA
21%
>target
GFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1jsuA
GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqj: CDK2 IN COMPLEX WITH INHIBITOR L2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qqjA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qqjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3le6: THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A PYRAZOLOBENZODIAZEPINE INHIBITOR Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3le6A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS----
>3le6A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIP-------STAIREISLLKELNHPNIVKLLDVIH--TKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
3pxq: CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALEN Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3pxqA
21%
>target
-----CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW-------E---KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3pxqA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6o: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2c6oA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LF----------WE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>2c6oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1w98: THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1w98A
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-------
>1w98A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
2r3q: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.35A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2r3qA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL------FW-----------------E---KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2r3qA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA---------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4acm: CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYLSULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE Solved by: X-RAY, Resolution: 1.63A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
4acmA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WEK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>4acmA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIH--TKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--------------------------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtz: CDK2 IN COMPLEX WITH INHIBITOR RC-2-36 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qtzA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qtzA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4bcq: STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4HETEROARYL-PYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
4bcqC
20%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWE--------------------------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-----
>4bcqC
SMENFQKVEKI--GEYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
328-604
4bcqA
21%
>target
---PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------F---WEK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL------
>4bcqA
PGSMENFQK---VEK--IGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
1hck: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
1hckA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>1hckA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3bht: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 3 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-605
3bhtA
21%
>target
--PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3bhtA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-604
3bhtC
23%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>3bhtC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2c6i: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
330-605
2c6iA
21%
>target
--DLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK------LFWE--------------------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2c6iA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5o: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 2.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2c5oA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS-----
>2c5oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
329-605
2c5oC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2c5oC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3sqq: CDK2 IN COMPLEX WITH INHIBITOR RC-3-96 Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-608
3sqqA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLFL-----
>3sqqA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARRTYT--------------------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vtr: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2vtrA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---E-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2vtrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rah: CDK2 IN COMPLEX WITH INHIBITOR RC-2-22 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-607
3rahA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF-------------------WE-------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSLF------
>3rahA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF----------------------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1gy3: PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1gy3A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1gy3A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1gy3C
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1gy3C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---------------------RTYHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qzi: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-126 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qziA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qziA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2cjm: MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATIONCDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-604
2cjmA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW-------E---KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL---
>2cjmA
MENFQKVEKIGEGT-GVVYKARNKLTGEVVALKKIRE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP
[Model]
329-605
2cjmC
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGK-SYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLF----------------W-------E---KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>2cjmC
MENFQKVEKIGEGT-GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1gz8: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1gz8A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNGKSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>1gz8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qru: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12 Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3qruA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3qruA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2exm: HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
2exmA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2exmA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ql8: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3ql8A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3ql8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qx4: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qx4A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qx4A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3unj: CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3unjA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3unjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3my5: CDK2/CYCLINA IN COMPLEX WITH DRB Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
328-605
3my5A
21%
>target
--PCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSVD--PFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3my5A
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-604
3my5C
23%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEAL-------
>3my5C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQ-LF-RIFRTLGVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1h1q: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
1h1qA
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h1qA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
329-605
1h1qC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKLFW--------------------------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS------
>1h1qC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qqf: CDK2 IN COMPLEX WITH INHIBITOR L1 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3qqfA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3qqfA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3lfn: CRYSTAL STRUCTURE OF CDK2 WITH SAR57, AN AMINOINDAZOLE TYPINHIBITOR Solved by: X-RAY, Resolution: 2.28A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3lfnA
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFWE----------KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3lfnA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA-----------------------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxf: CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALSULFONATE Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-605
3pxfA
21%
>target
-----CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL------------------------FWE--KFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>3pxfA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rk5: CDK2 IN COMPLEX WITH INHIBITOR RC-2-72 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3rk5A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3rk5A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3py0: CDK2 IN COMPLEX WITH INHIBITOR SU9516 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
329-606
3py0A
21%
>target
-CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIRCDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL----------------FW---EK-------FVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALSL-------
>3py0A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wih: STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
327-605
2wihA
21%
>target
---RPCDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVKL--------------------------FWEKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2wihA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
329-605
2wihC
21%
>target
--CDLIHGEVLGKGFFGQAIKVTHKATGKVMVMKELIR--CDEETQKTFLTEVKVMRSLDHPNVLKFIGVLYKDKKLNLLTEYIEGGTLKDFLRSV--DPFPWQQKVRFAKGISSGMAYLHSMCIIHRDLNSHNCLIKLDKTVVVADFGLSRLIVEERKRPPVEKATTKKRTLRKSDRKKRYTVVGNPYWMAPEMLNG-KSYDETVDVFSFGIVLCEIIGQVYADPDCLPRTLDFGLNVK----------------LFW----------EKFVPTDCPPAFFPLAAICCKLEPESRPAFSKL--EDSFEALS--------
>2wihC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]